Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Heidegger

Showing results (31-40 of 155) with videos related to

Pageof 16
Sort By:
Endocrinology|August 21, 2012
Diverse functions of IGF/insulin signaling in malignant and noncancerous prostate cells: proliferation in cancer cells and differentiation in noncancerous cellsIsabel Heidegger, Philipp Ofer, Wolfgang Doppler, et al.
Cancers|February 15, 2022
Molecular Mechanisms Related with Oligometastatic Prostate Cancer-Is It Just a Matter of Numbers?Cristian Surcel, Alexander Kretschmer, Cristian Mirvald, et al.
International Journal of Molecular Sciences|November 11, 2011
Biomarkers in tumor angiogenesis and anti-angiogenic therapyAndreas Pircher, Wolfgang Hilbe, Isabel Heidegger, et al.
International Journal of Medical Sciences|August 22, 2017
Urinary UBC Rapid and NMP22 Test for Bladder Cancer Surveillance in Comparison to Urinary Cytology: Results from a Prospective Single-Center StudyRenate Pichler, Gennadi Tulchiner, Josef Fritz, et al.
Urologie (Heidelberg, Germany)|August 6, 2024
[Molecular tumor boards in uro-oncology-prostate cancer]Frank Kunath, Isabel Heidegger, Matthias Heck, et al.
Journal of Cancer|November 21, 2017
Gender-related Outcome in Bladder Cancer Patients undergoing Radical CystectomyRenate Pichler, Josef Fritz, Isabel Heidegger, et al.
Plos One|July 29, 2015
Age-Adjusted PSA Levels in Prostate Cancer Prediction: Updated Results of the Tyrol Prostate Cancer Early Detection ProgramIsabel Heidegger, Josef Fritz, Helmut Klocker, et al.
Oncology|January 10, 2014
New antiangiogenic strategies beyond inhibition of vascular endothelial growth factor with special focus on axon guidance moleculesAndreas Pircher, Jasmin Wellbrock, Walter Fiedler, et al.
Anticancer Research|January 10, 2014
Latent hypothyreosis as a clinical biomarker for therapy response under abiraterone acetate therapyIsabel Heidegger, Udo Nagele, Andreas Pircher, et al.
Urologie (Heidelberg, Germany)|September 1, 2023
[Antibody-drug conjugates directed against NECTIN-4 as a new treatment option for patients with metastatic urothelial carcinoma]Niklas Klümper, Markus Eckstein, Frank Kunath, et al.
Pageof 16

Showing results (31-40 of 155) with videos related to

Sort By:
Pageof 16
Endocrinology|August 21, 2012
Diverse functions of IGF/insulin signaling in malignant and noncancerous prostate cells: proliferation in cancer cells and differentiation in noncancerous cellsIsabel Heidegger, Philipp Ofer, Wolfgang Doppler, et al.
Cancers|February 15, 2022
Molecular Mechanisms Related with Oligometastatic Prostate Cancer-Is It Just a Matter of Numbers?Cristian Surcel, Alexander Kretschmer, Cristian Mirvald, et al.
International Journal of Molecular Sciences|November 11, 2011
Biomarkers in tumor angiogenesis and anti-angiogenic therapyAndreas Pircher, Wolfgang Hilbe, Isabel Heidegger, et al.
International Journal of Medical Sciences|August 22, 2017
Urinary UBC Rapid and NMP22 Test for Bladder Cancer Surveillance in Comparison to Urinary Cytology: Results from a Prospective Single-Center StudyRenate Pichler, Gennadi Tulchiner, Josef Fritz, et al.
Urologie (Heidelberg, Germany)|August 6, 2024
[Molecular tumor boards in uro-oncology-prostate cancer]Frank Kunath, Isabel Heidegger, Matthias Heck, et al.
Journal of Cancer|November 21, 2017
Gender-related Outcome in Bladder Cancer Patients undergoing Radical CystectomyRenate Pichler, Josef Fritz, Isabel Heidegger, et al.
Plos One|July 29, 2015
Age-Adjusted PSA Levels in Prostate Cancer Prediction: Updated Results of the Tyrol Prostate Cancer Early Detection ProgramIsabel Heidegger, Josef Fritz, Helmut Klocker, et al.
Oncology|January 10, 2014
New antiangiogenic strategies beyond inhibition of vascular endothelial growth factor with special focus on axon guidance moleculesAndreas Pircher, Jasmin Wellbrock, Walter Fiedler, et al.
Anticancer Research|January 10, 2014
Latent hypothyreosis as a clinical biomarker for therapy response under abiraterone acetate therapyIsabel Heidegger, Udo Nagele, Andreas Pircher, et al.
Urologie (Heidelberg, Germany)|September 1, 2023
[Antibody-drug conjugates directed against NECTIN-4 as a new treatment option for patients with metastatic urothelial carcinoma]Niklas Klümper, Markus Eckstein, Frank Kunath, et al.
Pageof 16